Conference on Neurodegenerative Diseases and Treatments

CSHL 2024 Conference on Neurodegenerative Diseases: Biology & Therapeutics

NIH-funded research Cold Spring Harbor Laboratory · NIH-10994945

This conference is bringing together scientists and researchers to share ideas and discoveries about diseases like Alzheimer's and ALS, with the goal of finding better ways to understand and treat these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCold Spring Harbor Laboratory NIH-funded
Lab location1 site (Cold Spring Harbor, United States)
Project IDNIH-10994945 on NIH RePORTER

What this research studies

This conference will gather scientists and researchers to discuss the biology and treatment of neurodegenerative diseases such as Alzheimer's and ALS. Attendees will share their findings on disease mechanisms, potential biomarkers, and therapeutic strategies aimed at halting disease progression. The event will foster collaboration between academic and industry experts to advance understanding and treatment options for these conditions. It will include sessions on various aspects of neurodegeneration, including glial biology and immune responses.

Who could benefit from this research

Good fit: Patients with neurodegenerative diseases like Alzheimer's or ALS may benefit from the advancements discussed at this conference.

Not a fit: Patients with non-neurodegenerative conditions will likely not receive direct benefits from this conference.

Why it matters

Potential benefit: If successful, this conference could lead to new insights and collaborations that improve treatment options for patients with neurodegenerative diseases.

How similar studies have performed: Previous conferences on similar topics have successfully led to advancements in understanding and treating neurodegenerative diseases.

Where this research is happening

Cold Spring Harbor, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAmyotrophic Lateral Sclerosis Motor Neuron Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.